(Q46003964)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

0 references

1 reference

ChEBI release 2020-05-28

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ashraf Aminorroaya

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Peyman Adibi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Faramarz Ismail-Beigi

5

object named as

Faramarz Ismail-Beigi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Hassan Rezvanian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Masoud Amini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

1 reference

22 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

537-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21938543%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00592-011-0329-2

13 February 2020

exact match

0 references

cites work

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study, 1984-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

An immune origin of type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Potential role of salicylates in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Salsalate improves glycemia and inflammatory parameters in obese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Salicylates increase insulin secretion in healthy obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-011-0329-2